CI
Celularity Inc
🇺🇸XNAS.CELUUnited StatesHealthcare
$1.27USDup +0.02 (+1.6%)OpenDelayed2:24 PM
Price$1.27+0.02 (+1.6%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US1511902041
- CUSIP
- 151190105
Company
- Employees
- 115
- Headquarters
- Florham Park, United States
- Website
- https://www.celularity.com
- CEO
- Dr. Robert Joseph Hariri M.D., Ph.D.
Market
- Shares outstanding
- 28.9M
- Market cap
- $36.76M
Key dates
- Next earnings
- Sep 18, 2026
Highlights
- Market cap
- $36.47M
- EPS LTM
- -$3.76
- P/E LTM
- -0.35
- Div yield
- 0.19%
Fundamentals (LTM)
- Revenue
- $19.23M-66.66%down year on year
- Net income
- -$96.32M-190.68%down year on year
- Gross margin
- 47.05%-8.01%down year on year
- Free cash flow
- -$15.36M-659.09%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.